Succinimide | List of Frontiers open access articles

Original Research

Published on 08 May 2019

2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis

in Neurogenomics

Adam D. Kennedy
Kirk L. Pappan
Taraka Donti
Mauricio R. Delgado
Marwan Shinawi
Toni S. Pearson
Seema R. Lalani
William J. Craigen
V. Reid Sutton
Anne M. Evans

Frontiers in Neuroscience

doi 10.3389/fnins.2019.00394

9,768 views
38 citations

Original Research

Published on 15 Apr 2021

Lossen Rearrangement of p-Toluenesulfonates of N-Oxyimides in Basic Condition, Theoretical Study, and Molecular Docking

in Supramolecular Chemistry

Monika Kijewska
Abeer A. Sharfalddin
Łukasz Jaremko
Marta Cal
Bartosz Setner
Miłosz Siczek
Piotr Stefanowicz
Mostafa A. Hussien
Abdul-Hamid Emwas
Mariusz Jaremko

Frontiers in Chemistry

doi 10.3389/fchem.2021.662533

5,596 views
36 citations

Original Research

Published on 15 Jan 2020

Two-Stage Crystallization Combining Direct Succinimide Synthesis for the Recovery of Succinic Acid From Fermentation Broth

in Industrial Biotechnology

Yiwen Xiao
Zhibin Zhang
Ya Wang
Boliang Gao
Jun Chang
Du Zhu

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2019.00471

12,676 views
14 citations

Original Research

Published on 05 Apr 2022

Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab

in Medicinal and Pharmaceutical Chemistry

Tao Liu
Jin Xu
Qingcheng Guo
Dapeng Zhang
Jun Li
Weizhu Qian
Huaizu Guo
Xinli Zhou
Sheng Hou

Frontiers in Chemistry

doi 10.3389/fchem.2022.826923

7,332 views
4 citations

Original Research

Published on 11 Jul 2022

Isolation of Bioactive Compounds, Antibacterial Activity, and Action Mechanism of Spore Powder From Aspergillus niger xj

in Antimicrobials, Resistance and Chemotherapy

Longfeng Wei
Qinyu Zhang
Ailin Xie
Yang Xiao
Kun Guo
Shuzhen Mu
Yudan Xie
Zhu Li
Tengxia He

Frontiers in Microbiology

doi 10.3389/fmicb.2022.934857

9,446 views
27 citations

Correction

Published on 29 Jan 2020

Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis

in Neurogenomics

Adam D. Kennedy
Kirk L. Pappan
Taraka Donti
Mauricio R. Delgado
Marwan Shinawi
Toni S. Pearson
Seema R. Lalani
William J. Craigen
V. Reid Sutton
Anne M. Evans

Frontiers in Neuroscience

doi 10.3389/fnins.2019.01344

3,587 views
3 citations

Articles

2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis

Lossen Rearrangement of p-Toluenesulfonates of N-Oxyimides in Basic Condition, Theoretical Study, and Molecular Docking

Two-Stage Crystallization Combining Direct Succinimide Synthesis for the Recovery of Succinic Acid From Fermentation Broth

Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab

Isolation of Bioactive Compounds, Antibacterial Activity, and Action Mechanism of Spore Powder From Aspergillus niger xj

Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis